Beurel, Eléonore <br/><br/>
GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.  [electronic resource] 

 -  International journal of oncology  Jul 2005 
 - 215-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1019-6439 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Blotting, Western<br/>Camptothecin--pharmacology<br/>Carcinoma, Hepatocellular--pathology<br/>Caspase 3<br/>Caspase 8<br/>Caspases--metabolism<br/>Cell Line, Tumor<br/>Chromones--pharmacology<br/>Cytochromes c--metabolism<br/>DNA Fragmentation<br/>Enzyme Activation<br/>Enzyme Inhibitors--pharmacology<br/>Etoposide--pharmacology<br/>Flow Cytometry<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Morpholines--pharmacology<br/>Mutation<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Serine--chemistry<br/>Transfection<br/>Tumor Suppressor Protein p53--metabolism<br/>fas Receptor--metabolism